about
Association between body mass index and cardiovascular disease mortality in east Asians and south Asians: pooled analysis of prospective data from the Asia Cohort ConsortiumFractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapyDevelopment and validation of a clinical scoring system for predicting risk of HCC in asymptomatic individuals seropositive for anti-HCV antibodies.Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an East Asian country: a nationwide cancer registry-based study.Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma.Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients.Familial tendency and risk of nasopharyngeal carcinoma in taiwan: effects of covariates on risk.Gene methylation profiles as prognostic markers in ovarian clear cell and endometrioid adenocarcinomas.The Link of Self-Reported Insomnia Symptoms and Sleep Duration with Metabolic Syndrome: A Chinese Population-Based StudyTrends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan.Cancer trends in Taiwan.Epidemiology of virus infection and human cancer.Quality assessment and improvement of nationwide cancer registration system in Taiwan: a review.Secular trends in breast cancer mortality in five East Asian populations: Hong Kong, Japan, Korea, Singapore and Taiwan.Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.High hepatitis C viral load and genotype 2 are strong predictors of chronic kidney disease.Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study.Serum Levels of Hepatitis B Surface Antigen and DNA Can Predict Inactive Carriers With Low Risk of Disease Progression.Alcohol Drinking Mediates the Association between Polymorphisms of ADH1B and ALDH2 and Hepatitis B-Related Hepatocellular Carcinoma.Incidence and survival of adult cancer patients in Taiwan, 2002-2012.Aflatoxin B1 exposure increases the risk of cirrhosis and hepatocellular carcinoma in chronic hepatitis B virus carriers.Adverse prognosis and distinct progression patterns after concurrent chemoradiotherapy for glioblastoma with synchronous subventricular zone and corpus callosum invasion.Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan.Significant reduction in end-stage liver diseases burden through the national viral hepatitis therapy program in Taiwan.Predicting Hepatitis B Virus (HBV) Surface Antigen Seroclearance in HBV e Antigen-Negative Patients With Chronic Hepatitis B: External Validation of a Scoring System.Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: a prospective study in taiwan.Distinct seromarkers predict different milestones of chronic hepatitis B progression.Incomplete hepatitis B immunization, maternal carrier status, and increased risk of liver diseases: a 20-year cohort study of 3.8 million vaccinees.Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma.Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma.Impact of Worsened Metabolic Syndrome on the Risk of Dementia: A Nationwide Cohort StudyCommunity and personal risk factors for hepatitis C virus infection: a survey of 23,820 residents in Taiwan in 1991-2.Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.ABO blood group and the risk of cancer among middle-aged people in Taiwan.Thirty-year outcomes of the national hepatitis B immunization program in Taiwan.Association between obesity, hypertriglyceridemia and low hepatitis B viral load.Hepatitis C virus infection and increased risk of cerebrovascular disease.Metabolic syndrome and C-reactive protein concentration as independent correlates of chronic kidney disease.
P50
Q27022672-EA1ECD66-1C9C-4C73-827C-914BFF792548Q33568902-C3A4C280-279C-4FB2-96DB-4077F99C80C5Q33572715-CAF85A08-3352-4B4F-939A-BC4AF71FF7F9Q33699658-72C1F156-C9CA-4AAD-BC6A-A415B664CB2EQ33910326-75F5F4BD-5A3C-4215-BC37-BD33014EA7ACQ34684406-163A3985-609F-4763-9F4B-3A844BAF61F8Q35017418-D473B463-EAAF-4957-AF14-B4F78AF0A125Q35137818-2856A944-0BFC-4698-AFD6-551FC98AE40FQ36890137-86B7A840-D63B-41E6-ABB5-E7C42EFFA007Q37249302-6A654460-E60D-40FF-8C26-96AB88C042D9Q37759972-9E1A898C-0284-4A0B-872C-04FF2C8AE175Q38134541-E71FED1D-2369-45D2-91E6-A3E47ADDB4D2Q38324572-A74CC4F5-C6AD-49A0-9BAD-34DF416F9B66Q38446034-CDB9F097-E5A9-455B-8C44-42FAB226AD67Q38626183-2D86ED4B-ED2E-4384-AFDE-ECD9A82865B8Q38770305-A50F9493-0DA2-4789-B422-F2046B7377B3Q38859678-691E5D6F-AF32-4F0D-95FE-18EF3472CFC8Q38881102-D8BD0EC4-0BBC-421C-8026-7FBC3F4C23D2Q38914104-DB1F45E4-26CF-4309-A593-9E381395E60EQ40087291-C9D17C27-E8EA-4CB8-AE7D-DECE68F9DF76Q40199743-138D3CEB-723A-481F-94CD-3908EF4D095CQ40200939-40ADC33E-00AF-426F-9497-578346339531Q40780258-7FEB10E3-C0EE-43A4-935B-8C8AD951F3EBQ40880775-C3EFDA9B-2666-43BA-8F93-2A8A5EB54D7DQ41399387-BA6BD393-EB0C-4658-970C-A3E5FBBD7BD1Q42177592-E08A88FB-34E7-4612-BC14-2A9F3AF25DCAQ42180497-88DBF2CD-27E7-4161-8DA6-797AE254BBFDQ42214718-CFD63716-E339-4147-BF8A-69EB3106981EQ42226917-F2A72B88-367E-4271-8207-9B846B649400Q42229775-645C1907-0C79-4304-8020-F1E527462385Q42239862-B883C832-8B7E-492C-A74E-BE9AB58CB3A1Q42255811-FF3B2B34-BEDB-4317-B6EF-70A275EE8CA7Q42373661-A8F4DB5C-6561-4144-8B24-1868CEF9B9F7Q43001405-6459B6FE-8AAE-435F-8831-42FD7407EE76Q43973491-CC6AB241-4842-4C60-8E56-1F78ED872799Q44524641-78FD6C45-B038-4C3F-83AA-21000367C1F4Q44712948-050686D0-23D3-4223-968C-E01653C03431Q45153922-9FDAC37D-26D4-4548-9E09-FDCBA86452A6Q45372162-5BEDE195-90A5-4DD1-ACCA-1B3225ABC486Q46305724-DB2CD113-2905-4357-B9D6-C9ABBA49E47F
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
S-L You
@en
S-L You
@nl
type
label
S-L You
@en
S-L You
@nl
prefLabel
S-L You
@en
S-L You
@nl
P31
P496
0000-0002-3192-3356